Skip to main content
Premium Trial:

Request an Annual Quote

Institut Curie to Use Affy Arrays to Develop Cancer Diagnostics

NEW YORK, Feb. 2 (GenomeWeb News) - The Institut Curie of France will use Affymetrix microarrays in several large-scale clinical studies aimed at developing diagnostic tests for cancer, the two partners said today.

 

Institut Cure, a private cancer research center based in Paris, plans several translational medicine studies, based on its library of frozen tumor samples, which will use Affymetrix's GeneChip arrays.

 

The first two project aim to identify prognostic markers for breast cancer relapse and for metastasis of uveal melanoma, a form of eye cancer.